Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cervical Cancer & Gynecologic Oncology

Carien L. Creutzberg

卡里恩·克鲁茨贝格

MD, PhD

🏢Leiden University Medical Center(莱顿大学医学中心)🌐Netherlands

Professor of Radiation Oncology; Head, Gynecologic Radiation Oncology放射肿瘤学教授;妇科放射肿瘤科主任

72
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Carien L. Creutzberg, MD, PhD is Professor of Radiation Oncology at Leiden University Medical Center and the principal architect of the PORTEC (Post Operative Radiation Therapy in Endometrial Carcinoma) trial series. Her landmark trials have defined modern adjuvant radiation standards for endometrial cancer and contributed foundational evidence for cervical and uterine cancer radiotherapy.

Share:

🧪Research Fields 研究领域

Gynecologic Radiation Oncology妇科放射肿瘤学
Endometrial Cancer子宫内膜癌
PORTEC TrialsPORTEC试验
Cervical Cancer Radiotherapy宫颈癌放射治疗
Brachytherapy近距离放射治疗

🎓Key Contributions 主要贡献

PORTEC Trial Series: Defining Adjuvant Radiation in Endometrial Cancer

Led PORTEC-1, -2, and -3 trials that sequentially refined adjuvant radiotherapy for endometrial cancer, establishing vaginal brachytherapy as the preferred treatment for intermediate-risk patients and combining chemoradiation for high-risk disease.

Molecular Classification Integration in Endometrial Cancer Radiotherapy

PORTEC-3 and subsequent analyses integrated molecular classification (TCGA-based) with radiation therapy decisions, pioneering molecularly-guided radiation oncology in gynecologic cancers.

Representative Works 代表性著作

[1]

Adjuvant Radiotherapy for Endometrial Carcinoma (PORTEC-1)

The Lancet (2000)

Established that adjuvant pelvic radiotherapy reduces locoregional recurrence but does not improve overall survival in early endometrial cancer, fundamentally changing adjuvant treatment practice.

[2]

Vaginal Brachytherapy versus Pelvic Radiation for Intermediate-Risk Endometrial Cancer (PORTEC-2)

The Lancet (2010)

Showed vaginal brachytherapy is non-inferior to pelvic radiation with fewer side effects, establishing it as the new standard for intermediate-risk endometrial cancer.

🏆Awards & Recognition 奖项与荣誉

🏆ESTRO Honorary Membership
🏆ESGO Distinguished Scientist Award
🏆Netherlands Cancer Society Lifetime Achievement Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 卡里恩·克鲁茨贝格 的研究动态

Follow Carien L. Creutzberg's research updates

留下邮箱,当我们发布与 Carien L. Creutzberg(Leiden University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment